Random good picture Not show

1. CONCLUSION: Pharmacokinetics of CFR and TMR are similar.

2. The pharmacokinetics of IDEBENONE have not been extensively studied.

3. Objective To study the pharmacokinetics of netilmicin in rabbits.

4. Formulate the distribution of photosensitizer in vessels by pharmacokinetics.

5. OBJECTIVE: To compare the in vivo pharmacokinetics of gatifloxacin between normal canis familiaris and hepatic injury model group.

6. Objective To investigate the pharmacokinetics of clindamycin phosphate vagina gel in healthy Chinese female volunteers.

7. OBJECTIVE: Pharmacokinetics and bioavailability of domestic and imported moclobemide tablets after single - dose oral administration.

8. In this study, the pharmacokinetics of Oleuropein in rabbits were evaluated.

9. Objecdive To study pharmacokinetics and relative bioavailability of cefathiamidine and cefathiamidine salt in rabbit intramuscularly .

10. OBJECTIVE To study the pharmacokinetics of omeprazole ( OME ) in 8 patients with liver cirrhosis.

11. The pharmacokinetics of piracetam in rats is of the linear pharmacokinetic characteristic.

12. The structure - activity relationship, pharmacology , pharmacokinetics, clinical efficacy , ADRs, and drug interaction of mirtazapine antidepressant, are reviewed.

13. Pharmacokinetics, toxicological functions, drug residue, withdrawal time and the application perspective are summarized in this article.

14. Objective : To study the pharmacokinetics and bioavailability of cefalexin capsule.

15. The presented method can be used for the pharmacokinetics study of netilmicin in rat serum, and can be a new choice for the determination of aminoglycoside antibiotics in biological samples.

16. Conclusions: The changes of the pharmacokinetics were influenced not only by liver function and kidney function, acid-base balance, but also by sleep closed.

17. To study pharmacokinetics and availability of national - apramycin sulfate by oral and intravenous administration in 5 pigs.

18. Sustained release tablets(SRT)of labetalol and the human pharmacokinetics were studied.

19. OBJECTIVE : To study chiral pharmacokinetics process of amlodipine enantiomers of rabbits in vivo.

20. AIM To study the pharmacokinetics and bioavailability of clinafloxacin in rats.

21. Results: The mimesis accuracy of Grey pharmacokinetics model was higher than that of traditional ones.

22. Objective To study the pharmacokinetics and bioavailability of apigenin solid lipid nanoparticles after peroral administration in rats.

23. Objective To study the pharmacokinetics of cyclosporin A (CsA) with or without combination of berberine hydrochloride (Ber) in renal transplantation recipients.

24. Objective:To compare the pharmacokinetics, clinical characteristic and ratio of effective price of desflurane with isoflurane in closed circuit anesthesia.

25. OBJECTIVE To study the pharmacokinetics and bioequivalent of the domestic and imported cephradine injection in healthy volunteers.

26. The synthesis, physico-chemical properties, research on dosage forms, analysis, pharmacokinetics, mechanisms, clinical uses and new development in uses of disulfiram were reviewed.

27. AIM To develop a HPLC-UV method for determinating the concentration of zopiclone in human plasma and to compare the pharmacokinetics of zopiclone tablets of domestic vs imported.

28. Professor Saltzman starts the lecture with an introduction to pharmacokinetics and pharmacodynamics.

29. OBJECTIVE To develop an HPLC-MS/MS method for the determination of cyclobenzaprine in human plasma and study pharmacokinetics in healthy volunteers.

30. OBJECTIVE To prepare Gliclazide bioadhesive sustained release tablets and investigate the in vitro release characteristics,(Sentence dictionary) adhesion in the ex vivo tissues and the pharmacokinetics in beagle dogs.